Cite
HARVARD Citation
Rajapaksha, I. et al. (2022). Angiotensin Converting Enzyme‐2 Therapy Improves Liver Fibrosis and Glycemic Control in Diabetic Mice With Fatty Liver. Hepatology communications. 6 (5), pp. 1056-1072. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rajapaksha, I. et al. (2022). Angiotensin Converting Enzyme‐2 Therapy Improves Liver Fibrosis and Glycemic Control in Diabetic Mice With Fatty Liver. Hepatology communications. 6 (5), pp. 1056-1072. [Online].